RTÉ Ireland s National Tv And Radio Broadcaster.

Lenire is a bimodal neuromodulation tool which functions by delivering moderate electric pulses to the tongue, Bookmarks with an intra-oral element called the 'Tonguetip ®', incorporated with acoustic stimulation via headphones to drive long-term adjustments in the mind to deal with ringing in the ears.

Neuromod, which announced that FDA approval at a joint support and expert audiology meeting in the US has already received its initial US order and the initial shipment from its Letterkenny-based manufacturing companion, Philips-Medisize, was en route today.

Since the previous round of moneying raised in October 2020, the business has made development commercialising Lenire, expanding the device's schedule throughout Europe, developing a wholly owned US subsidiary, Neuromod U.S.A. Inc, and protecting US market authorization from the FDA.

The initial of these tests, TENT-A1, represents among the biggest and longest followed-up medical tests ever performed in the tinnitus area and was the cover story for the clinical journal Science Translational Medicine in October 2020.